triamcinolone acetonide has been researched along with Eye Cancer, Retinoblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blair, M; Kotlyar, B; Shapiro, M | 1 |
Bianciotto, C; Say, EA; Shields, CL; Shields, JA | 1 |
2 other study(ies) available for triamcinolone acetonide and Eye Cancer, Retinoblastoma
Article | Year |
---|---|
Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections, Intraocular; Intravitreal Injections; Macula Lutea; Male; Melphalan; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Triamcinolone Acetonide; Ultrasonography | 2019 |
Perilymphatic subcutaneous fat atrophy and cutaneous depigmentation after periocular triamcinolone acetonide injection in a child.
Topics: Adipose Tissue; Atrophy; Brachytherapy; Fascia; Female; Glucocorticoids; Humans; Hypopigmentation; Infant; Intravitreal Injections; Retinal Neoplasms; Retinoblastoma; Skin Pigmentation; Triamcinolone Acetonide | 2011 |